SMT202100074T1 - Uso di una composizione contenente benzoato in disturbi del ciclo dell'urea e disturbi neurodegenerativi - Google Patents
Uso di una composizione contenente benzoato in disturbi del ciclo dell'urea e disturbi neurodegenerativiInfo
- Publication number
- SMT202100074T1 SMT202100074T1 SM20210074T SMT202100074T SMT202100074T1 SM T202100074 T1 SMT202100074 T1 SM T202100074T1 SM 20210074 T SM20210074 T SM 20210074T SM T202100074 T SMT202100074 T SM T202100074T SM T202100074 T1 SMT202100074 T1 SM T202100074T1
- Authority
- SM
- San Marino
- Prior art keywords
- containing composition
- neurodegenerative disorders
- glyceryl tribenzoate
- tribenzoate
- glyceryl
- Prior art date
Links
- HIZCTWCPHWUPFU-UHFFFAOYSA-N Glycerol tribenzoate Chemical compound C=1C=CC=CC=1C(=O)OCC(OC(=O)C=1C=CC=CC=1)COC(=O)C1=CC=CC=C1 HIZCTWCPHWUPFU-UHFFFAOYSA-N 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461928622P | 2014-01-17 | 2014-01-17 | |
| PCT/US2015/011798 WO2015109215A1 (en) | 2014-01-17 | 2015-01-16 | The use of a benzoate containing composition in urea cycle disorders and neurodegenerativre disordrs |
| EP15737329.1A EP3094616B1 (en) | 2014-01-17 | 2015-01-16 | The use of glyceryl tribenzoate containing composition in neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT202100074T1 true SMT202100074T1 (it) | 2021-05-07 |
Family
ID=53543490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM20210074T SMT202100074T1 (it) | 2014-01-17 | 2015-01-16 | Uso di una composizione contenente benzoato in disturbi del ciclo dell'urea e disturbi neurodegenerativi |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9968582B2 (enExample) |
| EP (1) | EP3094616B1 (enExample) |
| JP (2) | JP6836905B2 (enExample) |
| CA (1) | CA2936548C (enExample) |
| CY (1) | CY1124115T1 (enExample) |
| DK (1) | DK3094616T3 (enExample) |
| ES (1) | ES2853974T3 (enExample) |
| HR (1) | HRP20210361T1 (enExample) |
| HU (1) | HUE053671T2 (enExample) |
| LT (1) | LT3094616T (enExample) |
| PL (1) | PL3094616T3 (enExample) |
| PT (1) | PT3094616T (enExample) |
| RS (1) | RS61611B1 (enExample) |
| SI (1) | SI3094616T1 (enExample) |
| SM (1) | SMT202100074T1 (enExample) |
| WO (1) | WO2015109215A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202090666A1 (ru) * | 2017-10-06 | 2020-08-05 | Раш Юниверсити Медикал Сентер | Применение содержащей бензоат композиции для лечения глициновой энцефалопатии |
| CA3076180C (en) | 2017-11-22 | 2022-05-17 | Excelsior Pharmatech Labs | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression |
| KR20210130772A (ko) | 2019-02-25 | 2021-11-01 | 러쉬 유니버시티 메디컬 센터 | 신남산을 포함하는 조성물 및 이의 이용 방법 |
| JP2022541021A (ja) * | 2019-07-16 | 2022-09-21 | ラッシュ・ユニバーシティ・メディカル・センター | 神経変性障害を治療するためのベンゾエート含有組成物の使用 |
| WO2022093922A1 (en) * | 2020-10-28 | 2022-05-05 | Rush University Medical Center | Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders |
| US20240100008A1 (en) * | 2020-12-16 | 2024-03-28 | Rush University Medical Center | Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders |
| CN118695857A (zh) * | 2021-12-16 | 2024-09-24 | 由退伍军人事务部代表的美国政府 | 用于治疗神经系统损伤和障碍的苯甲酸盐 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| US20080171792A1 (en) * | 2006-12-28 | 2008-07-17 | Jobdevairakkam Christopher New | Use of highly concentrated formulations of 4-phenylbutyrate for treatment of certain disorders |
-
2015
- 2015-01-16 SI SI201531511T patent/SI3094616T1/sl unknown
- 2015-01-16 HU HUE15737329A patent/HUE053671T2/hu unknown
- 2015-01-16 SM SM20210074T patent/SMT202100074T1/it unknown
- 2015-01-16 ES ES15737329T patent/ES2853974T3/es active Active
- 2015-01-16 DK DK15737329.1T patent/DK3094616T3/da active
- 2015-01-16 PT PT157373291T patent/PT3094616T/pt unknown
- 2015-01-16 LT LTEP15737329.1T patent/LT3094616T/lt unknown
- 2015-01-16 RS RS20210230A patent/RS61611B1/sr unknown
- 2015-01-16 EP EP15737329.1A patent/EP3094616B1/en active Active
- 2015-01-16 JP JP2016565117A patent/JP6836905B2/ja active Active
- 2015-01-16 CA CA2936548A patent/CA2936548C/en active Active
- 2015-01-16 WO PCT/US2015/011798 patent/WO2015109215A1/en not_active Ceased
- 2015-01-16 HR HRP20210361TT patent/HRP20210361T1/hr unknown
- 2015-01-16 PL PL15737329T patent/PL3094616T3/pl unknown
- 2015-01-16 US US15/110,702 patent/US9968582B2/en active Active
-
2019
- 2019-10-18 JP JP2019191224A patent/JP2020037558A/ja active Pending
-
2021
- 2021-03-09 CY CY20211100204T patent/CY1124115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20160331714A1 (en) | 2016-11-17 |
| LT3094616T (lt) | 2021-04-12 |
| EP3094616B1 (en) | 2020-12-23 |
| CA2936548C (en) | 2022-08-30 |
| DK3094616T3 (da) | 2021-02-15 |
| JP2020037558A (ja) | 2020-03-12 |
| CA2936548A1 (en) | 2015-07-23 |
| ES2853974T3 (es) | 2021-09-20 |
| RS61611B1 (sr) | 2021-04-29 |
| EP3094616A4 (en) | 2017-08-23 |
| PT3094616T (pt) | 2021-03-03 |
| US9968582B2 (en) | 2018-05-15 |
| JP2017505811A (ja) | 2017-02-23 |
| SI3094616T1 (sl) | 2021-07-30 |
| CY1124115T1 (el) | 2022-05-27 |
| HUE053671T2 (hu) | 2021-07-28 |
| HRP20210361T1 (hr) | 2021-04-16 |
| EP3094616A1 (en) | 2016-11-23 |
| WO2015109215A1 (en) | 2015-07-23 |
| JP6836905B2 (ja) | 2021-03-03 |
| PL3094616T3 (pl) | 2021-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3513809T (pt) | Composição medicinal compreendendo tivozanib | |
| IL252477A0 (en) | 2-aminopyrimidine compound, pharmaceutical structure and its use | |
| GB201411197D0 (en) | Composition and use thereof | |
| GB201403093D0 (en) | Therapeutic compounds and their use | |
| PL3018183T3 (pl) | Kompozycja na bazie fluorowcoolefiny i jej zastosowanie | |
| GB201408080D0 (en) | Skin care composition | |
| SG11201608217PA (en) | Fatty acid composition and use thereof | |
| SG11201605366QA (en) | Pharmaceutical composition containing pyridylaminoacetic acidcompound | |
| PL3094616T3 (pl) | Zastosowanie kompozycji zawierającej benzoesan w zaburzeniach cyklu mocznikowego i chorobach neurodegeneracyjnych | |
| ZA201704830B (en) | Cosmetic sunscreen composition | |
| IL251904B (en) | Epilimod for use in the treatment of melanoma | |
| HUE039750T2 (hu) | Hidroxi-buspiron mozgászavarok kezelésére | |
| ZA201606264B (en) | Personal care composition | |
| SG11201602573RA (en) | Skin cosmetic composition | |
| PL3102187T3 (pl) | Stabilne kompozycje farmaceutyczne zawierające sitagliptynę w postaci tabletek o natychmiastowym uwalnianiu | |
| GB201408079D0 (en) | Skin care composition | |
| GB201411196D0 (en) | Composition and use thereof | |
| IL248735A0 (en) | Preparations containing glycolipid for use in the treatment of tumors | |
| IL249852A0 (en) | Rubbing composition for oral treatment | |
| SG11201702334SA (en) | External preparation composition containing s-flurbiprofen | |
| IL252447A0 (en) | Compound for oral care | |
| ZA201606391B (en) | Personal care composition | |
| GB201513543D0 (en) | Compositions for use in the treatment of diabetes | |
| IL252994A0 (en) | Compound for oral care | |
| GB201404391D0 (en) | Novel compositions having use in therapy |